The Lewisville, Texax–base spine and ortho tech company announced today that it moving its Bone Growth Therapies business out from under the leadership of its Spine business.
Jason Shallenberger, previously the VP of U.S. sales and marketing for the Bone Growth Therapies business, is now Orthofix’s president of Bone Growth Therapies.
“Jason has led sales and marketing for this successful franchise for a number of years,” Orthofix President and CEO Massimo Calafiore said in a news release. “Under his guidance, the sales team has produced quarter-after-quarter of double-digit growth in 2023. I am confident he will do an amazing job as President and continue to contribute greatly to the success of Orthofix.”
Shallenberger said he was honored to take on the new role. “Since 1986, Orthofix Bone Growth Therapy has helped promote the natural-bone healing process in patients,” he said.
Shallenberger joined the company in 2005 as a territory manager, moving up the ranks over the years. From 2013 to 2023, he was VP of U.S. sales. The company said he led his team to 30 consecutive quarters of year-over-year growth, outpacing annual market growth rates.